top of page
Open Site Navigation
  • jocelyn981

Promising data for the treatment of Hurler MPS subtype

Orchard Therapeutics, a global gene therapy leader, announced data published in the New England Journal of Medicine (NEJM) evaluating the safety and efficacy of OTL-203 for the treatment of the Hurler subtype of Mucopolysaccharidosis type I (MPS-IH). Read more...

bottom of page